1. Adaptimmune Therapeutics Plc - ADR
  2. Executive Salaries
  3. Dr. Helen Tayton-Martin, PhD
person reading Dr. Helen Tayton-Martin, PhD's salary history.

Historical salary details - Dr. Helen Tayton-Martin, PhD, Chief Business and Strategy Officer, Adaptimmune Therapeutics Plc - ADR

Dr. Helen Tayton-Martin, PhD has been the Chief Business and Strategy Officer of Adaptimmune Therapeutics Plc - ADR since 01 Apr 2008. View his historical salary.

Dr. Helen Tayton-Martin, Phd

Chief Business and Strategy Officer

-
Gross Remuneration

  • Current Company

    Adaptimmune Therapeutics Plc - ADR
YEAR COMPANY POSITION SALARY INCREMENT
2024 Adaptimmune Therapeutics Plc - ADR Chief Business and Strategy Officer - -
2023 Adaptimmune Therapeutics Plc - ADR - 1.2 M -
2022 Adaptimmune Therapeutics Plc - ADR Chief Business and Strategy Officer - -
2021 Adaptimmune Therapeutics Plc - ADR Chief Business Officer 1.8 M 14.4 %
2020 Adaptimmune Therapeutics Plc - ADR Chief Business Officer 1.6 M 15.2 %
2020 Adaptimmune Therapeutics Plc - ADR - 1.6 M 14.8 %
2019 Adaptimmune Therapeutics Plc - ADR - 1.4 M 7.1 %
2019 Adaptimmune Therapeutics Plc - ADR - 1.4 M 6.6 %
2019 Adaptimmune Therapeutics Plc - ADR Chief Business Officer 1.4 M 5.8 %
2018 Adaptimmune Therapeutics Plc - ADR - 1.3 M -
2018 Adaptimmune Therapeutics Plc - ADR - 1.3 M -
2018 Adaptimmune Therapeutics Plc - ADR Chief Business Officer 1.3 M -
2017 Adaptimmune Therapeutics Plc - ADR - 1.4 M -
2017 Adaptimmune Therapeutics Plc - ADR - 1.4 M -
2017 Adaptimmune Therapeutics Plc - ADR Chief Business Officer - -
2016 Adaptimmune Therapeutics Plc - ADR - 1.1 M -
2016 Adaptimmune Therapeutics Plc - ADR Chief Business Officer - -
2015 Adaptimmune Therapeutics Plc - ADR Chief Operating Officer - -
2014 Adaptimmune Therapeutics Plc - ADR Chief Operating Officer - -